MedTrace Logo

Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study

NCT03369106 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-03-11

No results posted yet for this study

Summary

This study will identify a combination of disease severity markers (genetic, immunology, epigenetic, imaging) associated with disease severity and progression in a cohort of patients with multiple sclerosis.

Conditions

Interventions

OTHER

Composite severity score calculation

Neurological examination, cognitive testing, and MRI exam

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Céline Louapre, MD, PhD · Institut du Cerveau et de la Moelle Epinière

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-06
Primary Completion
2020-12-15
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03369106 on ClinicalTrials.gov